Melbourne researchers are looking for people infected with COVID-19 to participate in a trial of an antiviral medication that could speed up their recovery.
The Alfred and Monash University are enrolling symptomatic people with COVID-19 in the first five days of diagnosis to trial Favipiravir, a drug originally developed to treat people with influenza.
Trials are already underway in multiple countries including China, Japan and the United States.
https://7news.com.au/lifestyle/health-wellbeing/new-vic-virus-trial-could-hasten-recovery-c-1225532
Favipiravir , Alfred and Monash Uni .
Melbourne researchers are looking for people infected with...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $94.80M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 23.5¢ | $140.9K | 586.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12010 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 70000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
-0.010 ( 4.08 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.5¢ | 23.5¢ | 164909 | ||
| Last updated 15.58pm 26/04/2024 ? | |||||
| PAA (ASX) Chart |